We are live on ! Find out more
SCM

Soleus Capital Management Portfolio holdings

AUM $2.47B
1-Year Est. Return 115.63%
This Fund
S&P 500
This Quarter Est. Return
-11.17%
1 Year Est. Return
+115.63%
3 Year Est. Return
+435.52%
5 Year Est. Return
+604.31%
10 Year Est. Return
–
AUM
$775M
AUM Growth
-$224M
Cap. Flow
-$90.9M
Cap. Flow %
-11.73%
Top 10 Hldgs %
46.3%
Holding
85
New
17
Increased
18
Reduced
18
Closed
20

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$27M
2
OSUR icon
OraSure Technologies
OSUR
+$24.4M
3
ILMN icon
Illumina
ILMN
+$21.6M
4
ACLX
Arcellx
ACLX
+$16.5M
5
HOLX
Hologic
HOLX
+$16.2M

Top Sells

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$59.5M
2
AZN icon
AstraZeneca
AZN
+$21.9M
3
CCCC icon
C4 Therapeutics
CCCC
+$9.58M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$7.53M
5
SNN icon
Smith & Nephew
SNN
+$6.99M

Sector Composition

Rank Sector Weight
1 Healthcare 80.09%
2 Financials 0.5%
3 Consumer Staples 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYRA
76
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-200
Closed -$44K
VNDA icon
77
Vanda Pharmaceuticals
VNDA
$302M
– –
-158,700
Closed -$2.49M
XBI icon
78
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-1,292,000
Closed -$145M
CUTR
79
DELISTED
Cutera, Inc.
CUTR
– –
-86,180
Closed -$3.56M
NGM
80
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-13,000
Closed -$230K
KDNY
81
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-298,700
Closed -$4.87M
CCXI
82
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-68,320
Closed -$2.49M
ARNA
83
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-40,000
Closed -$3.72M
ZGNX
84
DELISTED
Zogenix, Inc.
ZGNX
– –
-175,152
Closed -$2.85M
1 2 3
4

Similar funds

TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Q
QVR San Francisco, California $2.49B AUM 48.58% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.49B AUM 17.24% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return

Soleus Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Soleus Capital Management held 85 positions worth $775M, down 22% from $999M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Soleus Capital Management withdrew a net $90.9M in Q1 2022, closing 20 positions and reducing 18 holdings. Its most notable exit was Bioventus, an estimated $6.21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 71% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Soleus Capital Management opened a new position in OraSure Technologies worth $20.7M.

  • Soleus Capital Management's largest Q1 2022 buy was OraSure Technologies: 3,055,193 shares worth $20.7M.
  • Soleus Capital Management added most to United Therapeutics in Q1 2022, an estimated $27M increase.
  • Soleus Capital Management's biggest Q1 2022 reduction was Lantheus, cutting an estimated $59.5M.
  • Soleus Capital Management fully exited Bioventus in Q1 2022, selling an estimated $6.21M.
  • Soleus Capital Management's ten largest holdings make up 46% of its $775M portfolio in Q1 2022.
  • Soleus Capital Management opened 17 new positions and closed 20 in Q1 2022.
  • Soleus Capital Management's portfolio value fell 22% quarter-over-quarter to $775M.

Based on Soleus Capital Management's 13F filing for Q1 2022, filed 16 May 2022.